Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" Region.

about

Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores.

P2860

Q47416768-B13B7845-F9B6-41B6-A934-C8EF31A722D8

P2860

Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" Region.

Item

http://www.wikidata.org/entity/Q39252003

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" Region.

@en

Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" Region.

@nl

type

Item

label

Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" Region.

@en

Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" Region.

@nl

prefLabel

Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" Region.

@en

Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" Region.

@nl

P1476

Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" Region

@en

P2093

Fabrizio Micheli

http://www.w3.org/2001/XMLSchema#string

P2860

Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in t

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor

Principles of early drug discovery.

Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D₃ receptor antagonists.

Dopamine D3 receptor ligands with antagonist properties.

Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.

Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.

Molecular determinants of selectivity and efficacy at the dopamine D3 receptor.

Caco-2 cell permeability assays to measure drug absorption.

P304

1254-1260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201700148

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fabrizio Micheli

P577

2017-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28426179

http://www.w3.org/2001/XMLSchema#string

P921

dopamine

Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" Region.

about

P2860

P2860

Novel, Selective, and Developable Dopamine D3 Antagonists with a Modified "Amino" Region.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921